168 related articles for article (PubMed ID: 9419046)
21. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
Gordeladze JO
Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of a phosphodiesterase III in the lysis-sensitive target-induced elevation of cyclic AMP (cAMP) in human natural killer cells.
Whalen MM; Crews JD
Biochem Pharmacol; 2000 Aug; 60(4):499-506. PubMed ID: 10874124
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue.
Giembycz MA; Barnes PJ
Biochem Pharmacol; 1991 Jul; 42(3):663-77. PubMed ID: 1650218
[TBL] [Abstract][Full Text] [Related]
25. Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion.
Parker JC; VanVolkenburg MA; Ketchum RJ; Brayman KL; Andrews KM
Biochem Biophys Res Commun; 1995 Dec; 217(3):916-23. PubMed ID: 8554616
[TBL] [Abstract][Full Text] [Related]
26. Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells.
Stefan E; Wiesner B; Baillie GS; Mollajew R; Henn V; Lorenz D; Furkert J; Santamaria K; Nedvetsky P; Hundsrucker C; Beyermann M; Krause E; Pohl P; Gall I; MacIntyre AN; Bachmann S; Houslay MD; Rosenthal W; Klussmann E
J Am Soc Nephrol; 2007 Jan; 18(1):199-212. PubMed ID: 17135396
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
[TBL] [Abstract][Full Text] [Related]
28. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
29. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D
Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933
[TBL] [Abstract][Full Text] [Related]
30. Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Tsuboi Y; Shankland SJ; Grande JP; Walker HJ; Johnson RJ; Dousa TP
J Clin Invest; 1996 Jul; 98(2):262-70. PubMed ID: 8755633
[TBL] [Abstract][Full Text] [Related]
31. Protein kinase C modulates cAMP content in proximal tubular cells: role of phosphodiesterase inhibition.
Le Goas F; Amiel C; Friedlander G
Am J Physiol; 1991 Oct; 261(4 Pt 2):F587-92. PubMed ID: 1656779
[TBL] [Abstract][Full Text] [Related]
32. Regulation of adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in UMR-106 osteoblast-like cells: role of cAMP-phosphodiesterase and cAMP efflux.
Ahlström M; Lamberg-Allardt C
Biochem Pharmacol; 1999 Oct; 58(8):1335-40. PubMed ID: 10487537
[TBL] [Abstract][Full Text] [Related]
33. Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.
Coffey AK; O'Sullivan DJ; Homma S; Dousa TP; Valtin H
Am J Physiol; 1991 Oct; 261(4 Pt 2):F640-6. PubMed ID: 1656782
[TBL] [Abstract][Full Text] [Related]
34. Functional plasticity of cyclic AMP hydrolysis in rat adenohypophysial corticotroph cells.
Ang KL; Antoni FA
Cell Signal; 2002 May; 14(5):445-52. PubMed ID: 11882389
[TBL] [Abstract][Full Text] [Related]
35. The phosphodiesterase 3 inhibitor cilostamide enhances inotropic responses to glucagon but not to dobutamine in rat ventricular myocardium.
Juan-Fita MJ; Vargas ML; Hernández J
Eur J Pharmacol; 2005 Apr; 512(2-3):207-13. PubMed ID: 15840406
[TBL] [Abstract][Full Text] [Related]
36. Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.
Kyoi T; Oka M; Noda K; Ukai Y
Life Sci; 2004 Aug; 75(15):1833-42. PubMed ID: 15302227
[TBL] [Abstract][Full Text] [Related]
37. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
Dousa TP
Kidney Int; 1999 Jan; 55(1):29-62. PubMed ID: 9893113
[TBL] [Abstract][Full Text] [Related]
38. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
39. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cyclic-3',5'-nucleotide phosphodiesterase abrogates the synergism of hypoxia with lipopolysaccharide in the induction of macrophage TNF-alpha production.
Meng X; Ao L; Shames BD; Harken AH
J Surg Res; 2001 Dec; 101(2):210-5. PubMed ID: 11735278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
